Received Jun 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4L454 | — |
Incorrect Vaccine; Received at 16 months of age; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 16-month-old male patient who received DTPa-IPV (Kinrix) (batch number 4L454, expiry date 16-OCT-2026) for prophylaxis. Co-suspect products included DTPa (DTaP vaccine) for prophylaxis. On 16-JUN-2025, the patient received Kinrix. On an unknown date, the patient did not receive DTaP vaccine. On 16-JUN-2025, an unknown time after receiving Kinrix and not applicable after receiving DTaP vaccine, the patient experienced wrong vaccine administered (Verbatim: Incorrect Vaccine) and inappropriate age at vaccine administration (Verbatim: Received at 16 months of age). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 17-JUN-2025 The nurse reported that they had a medication error and calling to see about any actions or anything that they should take as a result. Essentially, they had a 16-months old child who received a Kinrix vaccine that was not indicated until the age of four, which led to inappropriate age at vaccine administration. The patient was going to receive a DTAP vaccine and instead he received a DTAP/IPV vaccine, which led to wrong vaccine administered.